{
  "paper_metadata": {
    "pmid": "39456660",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "hgOvCa"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high-grade ovarian carcinoma",
          "evidence_sentence": "In hgOvCa, the only marker found to be predictive of response to chemotherapy were genetic variants in BRCA2."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high-grade ovarian carcinoma",
          "evidence_sentence": "Polymorphisms in this gene positively affected both the CR and PS in patients with tumors without the TP53 protein accumulation."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 52,
          "age_at_onset": 51,
          "age_at_diagnosis": 51,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high-grade ovarian carcinoma",
          "evidence_sentence": "The genetic variants in BRCA2 revealed their favorable prognostic value as well by decreasing the risk of death in the whole group of patients."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 55,
          "age_at_onset": 54,
          "age_at_diagnosis": 54,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 62,
          "age_at_onset": 60,
          "age_at_diagnosis": 61,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 65,
          "age_at_onset": 63,
          "age_at_diagnosis": 64,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 72,
          "age_at_onset": 70,
          "age_at_diagnosis": 71,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 75,
          "age_at_onset": 73,
          "age_at_diagnosis": 74,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "In the subgroup treated with TP, and in patients with tumors without TP53 accumulation."
        }
      ],
      "functional_data": {
        "summary": "The genetic variants in BRCA2 were found to have a favorable prognostic value.",
        "assays": [
          "Western blot analysis",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "not specified",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "BRCA2 variants were associated with positive outcomes in hgOvCa.",
      "key_quotes": [
        "The genetic variants in BRCA2 revealed their favorable prognostic value as well by decreasing the risk of death in the whole group of patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data was based on the detailed descriptions provided in the main text."
  }
}